Amedeo's Top 20

Amedeo Smart

Independent Medical Education

30 May 2022

Multidisciplinary Journal Club

  1. Cornelis MC, Bennett DA, Weintraub S, Schneider JA, et al.
    Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
    Ann Neurol 2022;91:834-846.

  1. Delgado-Lista J, Alcala-Diaz JF, Torres-Pena JD, Quintana-Navarro GM, et al.
    Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.
    Lancet 2022.

  2. Brill L, Raposo C, Rechtman A, Zveik O, et al.
    SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab.
    Ann Neurol 2022.

  3. Esmail A, Oelofse S, Lombard C, Perumal R, et al.
    An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
    Am J Respir Crit Care Med 2022;205:1214-1227.

  4. Li Z, Heckman MG, Kanekiyo T, Martens YA, et al.
    Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment.
    Neurology 2022;98:e2036-e2045.

  1. Cox H, Workman L, Bateman L, Franckling-Smith Z, et al.
    Oral swabs tested with Xpert MTB/RIF Ultra for diagnosis of pulmonary tuberculosis in children: a diagnostic accuracy study.
    Clin Infect Dis 2022.

  2. De Jager V, Gupte N, Nunes S, Barnes GL, et al.
    Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
    Am J Respir Crit Care Med 2022;205:1228-1235.

  3. D'Haens GR, Sandborn WJ, Loftus EV Jr, Hanauer SB, et al.
    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
    Gastroenterology 2022;162:1876-1890.

  4. Farlay D, Rizzo S, Dempster DW, Huang S, et al.
    Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years.
    J Bone Miner Res 2022;37:856-864.

  5. Uraki R, Kiso M, Iida S, Imai M, et al.
    Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2.
    Nature 2022.

  1. Jin J, Tang Y, Hu C, Jiang LM, et al.
    Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).
    J Clin Oncol 2022;40:1681-1692.

  2. Dinkele R, Gessner S, McKerry A, Leonard B, et al.
    Aerosolization of Mycobacterium tuberculosis by Tidal Breathing.
    Am J Respir Crit Care Med 2022.

  3. Landry C, Dorling J, Kulkarni K, Campbell-Yeo M, et al.
    Post discharge iron status in very preterm infants receiving prophylactic iron supplementation after birth.
    J Pediatr 2022.

  4. Calabretta E, Hamadani M, Carlo-Stella C.
    THE ANTIBODY-DRUG CONJUGATE LONCASTUXIMAB TESIRINE FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA.
    Blood 2022.

  5. Shen J, Amari N, Zack R, Skrinak RT, et al.
    Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson's Disease.
    Ann Neurol 2022.

  1. Sembill JA, Knott M, Xu M, Roeder SS, et al.
    Simplified Edinburgh CT Criteria for Identification of Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid Angiopathy.
    Neurology 2022.

  2. Bidard FC, Kaklamani VG, Neven P, Streich G, et al.
    Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERAL
    J Clin Oncol 2022.

  3. Pensato U, Baraldi C, Favoni V, Mascarella D, et al.
    Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.
    Cephalalgia 2022;42:645-653.

  4. Koole SN, Schouten PC, Hauke J, Kluin RJC, et al.
    Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer - results from the phase III OVHIPEC trial.
    Int J Cancer 2022.

  5. Soe MH, Chiang JM, Flavell RR, Khanafshar E, et al.
    Non-iodine Avid Disease is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer with Papillary Histology.
    J Clin Endocrinol Metab 2022.


more..

Privacy Policy